share_log

UroGen Pharma Ltd | 424B4: Prospectus

SEC ·  Jan 23, 2018 05:07
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.